N-(1H-imidazol-2-yl)benzamide compound of formula (I), or a pharmaceutically acceptable salt, a prodrug, a solvate, or a stereoisomer thereof which is a novel compound exhibiting excellent inhibitory activity against IRAK-4, can be used without side effects for efficient prevention and treatment of diseases mediated by IRAK-4 receptors, particularly autoimmune diseases or lymphomas.
N-(
1H-咪唑-2-基)苯甲酰胺化合物的
化学式(I),或其药学上可接受的盐、前药、溶剂合物或立体异构体,是一种新型化合物,表现出对IRAK-4的优异抑制活性,可用于高效预防和治疗由IRAK-4受体介导的疾病,特别是自身免疫疾病或淋巴瘤,且无副作用。